| AMAG Pharmaceuticals Provides Business Update - MarketWatch (press release) |
|
|
MarketWatch (press release) Over the course of 2011, the company successfully completed the transition of Feraheme(R) provider demand from both dialysis and non-dialysis sites of care to entirely non-dialysis sites of care. Feraheme non-dialysis provider demand for the fourth |